AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Aug 16, 2005

30339_dirs_2005-08-16_459e0f2f-2855-4451-b40c-0967c147026a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-08-12

Reporting Person: ELLERS STEVEN A (COO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-08-12	Common Stock	A	16.21	$26.6200	Acquired	16367.1420	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	85030.4663	Direct
Common Stock	2781.6880	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement and tax withholding for vested shares.